Posted in | News | Iron Ore | Mining Business

Rio Tinto Approves US$933 Million Investment to Extend Life of Marandoo Iron Ore Mine

Rio Tinto approves US$933 million extension of Marandoo iron ore mine life in Western Australia's Pilbara region

Rio Tinto has approved a US$933 million investment (Rio Tinto share 100%) to extend the life of the Marandoo iron ore mine by 16 years to 2030.

Rio Tinto chief executive Iron Ore and Australia, Sam Walsh said the Marandoo extension plays an important role in sustaining the Pilbara operations' annual capacity rate, complementing the major expansion programmes now underway.

Located 35km north east of the town of Tom Price, the project will extend the Marandoo mine life at its current mining rate of 15 million tonnes a year by developing the adjacent reserves below the water table.

Sam Walsh said, "With a high iron and low phosphorus content, Marandoo's Marra Mamba ore assists in maintaining the Pilbara Blend grade requirements and maximising the value of our integrated Pilbara operations.

"It also underlines our ability to develop projects to sustain tonnage at the same time as expanding our overall production capability."

One component of the Marandoo project is a water management strategy to manage the operation's dewatering, including priority water delivery to the Tom Price township and mine operations, the reinjection of water into the Southern Fortescue borefield to the north and a proposed irrigated agriculture scheme.

The project includes the construction of a wet processing plant and on-site facilities, an accommodation village and construction camp and additional mining fleet.

The project requires a number of Government and regulatory approvals, all of which have been received or are progressing well and on schedule.

Source:

Rio Tinto

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.